KRM Ayurveda Limited
Bookbuilding IPO · NSE
- Price band
- ₹128 - ₹135
- Lot size
- 1,000 shares
- Issue amount
- ₹77.49 cr
- Total subscription
- 74.43×
- Opens
- 21 Jan 2026
- Closes
- 23 Jan 2026
- Allotment
- 27 Jan 2026
- Listing
- 29 Jan 2026
Offer at a glance
Issue overview
- Issue size
- 57,40,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,28,000
- Fresh issue
- ₹77.49 cr
- Offer for sale
- ₹0 cr
- Registrar
- Skyline Financial Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,35,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 1,55,20,800
- Shares after issue
- 2,12,60,800
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 2,000 | ₹2,70,000 |
| sHNI | 3 | 3,000 | ₹4,05,000 |
| bHNI | 8 | 8,000 | ₹10,80,000 |
Share reservation
Subscription & GMP
Subscription by category
Reported 23 Jan 2026
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | 0 | 58 |
| NIB | 0 | 16,637 |
| RETAIL | 906 | 49,111 |
| HNIs(10L +) | 173 | 10,615 |
| HNIs (2-10L) | 87 | 6,022 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 13.93 | 882.06 |
| FIIs | 0 | 131.37 |
| FIs | 0 | 14.05 |
| Mutual Funds | 0 | 0.09 |
| Others | 0 | 736.55 |
| RETAIL | 24.46 | 1,326 |
| HNIs 2+ | 3.51 | 256.37 |
| HNIs 10+ | 7.02 | 1,176.78 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Sep-25 | Mar-25 | Mar-24 |
|---|---|---|---|
| EPS | 0 | 0 | 0 |
| ROE | 21.84 | 67.86 | 33.88 |
| ROCE | 21.84 | 43.33 | 20.8 |
| RONW | 5.24 | 8.06 | 2.27 |
| PRE IPO(PE) | 0 | 17.32 | 0 |
| POST IPO(PE) | 23.73 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| KRM Ayurveda Limited | 17.32 | 135.00 | 10.00 | 25.64 | 27.13 | 5.24 |
| Jeena Sikho Lifecare Limited | 76.58 | 678.50 | 2.00 | 142.24 | 31.28 | 8.86 |
| Vaidya Sane Ayurved Laboratories Limited | 93.20 | 286.00 | 10.00 | 59.85 | 5.12 | 3.07 |
Company information
Company profile
Incorporated on 3 September 2019, KRM Ayurveda Ltd operates a network of hospitals and clinics across several cities in India and has also expanded its presence internationally through telemedicine consultations and online sales. The company is engaged in manufacturing Ayurvedic products, including herbal and botanical remedies, medicines, supplements, and wellness or skincare-related items. Currently, it manages six hospitals and five clinics at different locations in the country, offers teleconsultation services, and sells KRM Ayurveda products, with a total workforce of 429 employees across various departments as of August 31, 2025.
Strengths
- Qualified Ayurvedic Professionals: Experienced doctors and certified therapists ensure consistent treatment quality.
- GMP-Certified Manufacturing: Centralized GMP facility ensures safe and effective Ayurvedic medicines.
- Trusted Brand & Repeat Clients: Strong patient trust leads to recurring business and brand strength.
Risk factors
- Non-Ownership of Premises: Operations run from leased hospitals and offices, and relocation could disrupt services.
- Employee Attrition Risk: High attrition among frontline and technical staff may affect service quality and growth.
- Geographical Revenue Concentration: Dependence on two key states increases exposure to regional risks.
Promoters
Mr. Puneet Dhawan
Mrs. Tanya Dhawan
Registrar & documents
Lead manager
NEXGEN Financial Solutions Private Limited
Registrar & contacts
Skyline Financial Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
A-16 G T Karnal road North West Delhi, New Delhi, 110033
+91- 9289101700
[email protected]Company website ↗Understanding KRMAYURVED IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.